ASBP logo

ASBP Aspire Biopharma Holdings, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$8.85
+0.07 (+0.80%)

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain ma…

Market Cap: $1.02Maspirebiolabs.com

Price

No data yet.

Social Signal Score

47
5d
—
30d
45
1 mentions
—
60d
48
2 mentions
—
90d
48
2 mentions
—
news: 2

Revenue

$63.1K
$0.00$21.0K$42.1K$63.1K
Mar 2021Jun 2026

Company Profile

CEO
Kraig T. Higginson
Sector
Healthcare
Industry
Biotechnology
Employees
2
Beta
0.15
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
-3.43
aspirebiolabs.com